data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Onconova Therapeutics
(NASDAQ:ONTX)
$1.295
-0.025[-1.89%]
At close: Jul 1
$1.29
-0.0050[-0.39%]
After Hours: 4:51PM EDT
Day High/Low1.29 - 1.32
52 Week High/Low1 - 7.08
Open / Close1.32 / 1.3
Float / Outstanding20.8M / 20.9M
Vol / Avg.31.2K / 99.4K
Mkt Cap27.1M
P/E-
50d Avg. Price1.26
Div / Yield-
Payout Ratio-
EPS-0.2
Total Float20.8M

Onconova Therapeutics (NASDAQ:ONTX), Quotes and News Summary

Onconova Therapeutics (NASDAQ: ONTX)

Day High/Low1.29 - 1.32
52 Week High/Low1 - 7.08
Open / Close1.32 / 1.3
Float / Outstanding20.8M / 20.9M
Vol / Avg.31.2K / 99.4K
Mkt Cap27.1M
P/E-
50d Avg. Price1.26
Div / Yield-
Payout Ratio-
EPS-0.2
Total Float20.8M
Benzinga - Jun 13, 2022, 8:19AM
Benzinga - Jun 13, 2022, 8:04AM
Benzinga - May 11, 2022, 4:09PM
Benzinga - Apr 27, 2022, 10:25AM
Benzinga - Mar 17, 2022, 4:12PM
Benzinga - Mar 1, 2022, 8:29AM
Benzinga - Dec 2, 2021, 8:05AM
Benzinga - Nov 11, 2021, 4:04PM
Benzinga - Sep 28, 2021, 4:06PM
Benzinga - Sep 24, 2021, 9:24AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.190-0.200 -0.0100
REV80.000K56.000K-24.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Onconova Therapeutics Questions & Answers

Q
How do I buy Onconova Therapeutics (ONTX) stock?
A

You can purchase shares of Onconova Therapeutics (NASDAQ: ONTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Onconova Therapeutics's (ONTX) competitors?
Q
What is the target price for Onconova Therapeutics (ONTX) stock?
A

The latest price target for Onconova Therapeutics (NASDAQ: ONTX) was reported by Ladenburg Thalmann on Tuesday, March 1, 2022. The analyst firm set a price target for 7.00 expecting ONTX to rise to within 12 months (a possible 440.54% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Onconova Therapeutics (ONTX)?
A

The stock price for Onconova Therapeutics (NASDAQ: ONTX) is $1.295 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Onconova Therapeutics (ONTX) pay a dividend?
A

There are no upcoming dividends for Onconova Therapeutics.

Q
When is Onconova Therapeutics (NASDAQ:ONTX) reporting earnings?
A

Onconova Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Onconova Therapeutics (ONTX) going to split?
A

There is no upcoming split for Onconova Therapeutics.

Q
What sector and industry does Onconova Therapeutics (ONTX) operate in?
A

Onconova Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.